Current Value of Holding

$1.03B

Shares

20M

% of Portfolio

0.84%

Average Buy Price

$127

Avg closing price
Price range

30 Baillie Gifford Moderna Trades

Baillie Gifford's position in Moderna is currently worth $1.03B. That's 0.84% of their equity portfolio (24th largest holding). The investor owns 5.51% of the outstanding Moderna stock. The first Moderna trade was made in Q4 2018. Since then Baillie Gifford bought shares thirteen more times and sold shares on sixteen occasions. The investor's estimated purchase price is $2.54B, resulting in a loss of 59%.

Avg closing price
Price range
Sold 2.9% shares (-595k shares) Q1 2026
Avg closing price $46.46
Price range $30.86 - $57.80
Sold 5.8% shares (-1.27M shares) Q4 2025
Avg closing price $26.81
Price range $22.36 - $34.90
Sold 1.1% shares (-247k shares) Q3 2025
Avg closing price $27.88
Price range $23.51 - $34.67
Sold 11.4% shares (-2.85M shares) Q2 2025
Avg closing price $26.30
Price range $23.65 - $28.54
Sold 35.8% shares (-13.9M shares) Q1 2025
Avg closing price $35.55
Price range $28.35 - $47.53
Sold 8.4% shares (-3.57M shares) Q4 2024
Avg closing price $47.55
Price range $36.85 - $63.93
Sold 2.3% shares (-991k shares) Q3 2024
Avg closing price $91.96
Price range $63.64 - $125.14
Sold 2.7% shares (-1.21M shares) Q2 2024
Avg closing price $126.55
Price range $101.21 - $166.61
Sold 2.2% shares (-999k shares) Q1 2024
Avg closing price $100.80
Price range $85.37 - $115.44
Increased shares by 0.0% (+5.34k shares) Q4 2023
Avg closing price $84.11
Price range $69.51 - $104.43
Sold 0.1% shares (-61.9k shares) Q3 2023
Avg closing price $111.55
Price range $96.41 - $126.61
Sold 1.6% shares (-755k shares) Q2 2023
Avg closing price $133.40
Price range $118.50 - $160.53
Increased shares by 3.7% (+1.68M shares) Q1 2023
Avg closing price $164.97
Price range $135.66 - $197.02
Sold 1.1% shares (-493k shares) Q4 2022
Avg closing price $163.51
Price range $118.38 - $210.04
Sold 0.6% shares (-280k shares) Q3 2022
Avg closing price $151.74
Price range $118.07 - $194.18
Sold 0.2% shares (-69.4k shares) Q2 2022
Avg closing price $142.94
Price range $117.13 - $176.59
Sold 0.3% shares (-143k shares) Q1 2022
Avg closing price $168.36
Price range $126.46 - $235.05
Increased shares by 8.4% (+3.55M shares) Q4 2021
Avg closing price $292.38
Price range $225.82 - $368.51
Sold 8.0% shares (-3.67M shares) Q3 2021
Avg closing price $368.80
Price range $221.90 - $484.47
Increased shares by 1.2% (+545k shares) Q2 2021
Avg closing price $178.71
Price range $129.91 - $234.98

News about Moderna Inc and Baillie Gifford

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!